Jacobi Capital Management’s PROVECTUS BIOPHARMACEUTICALS, INC. (DE) PVCT Stock Holding History

Jacobi Capital Management’s Portfolio PVCT Stock Details PVCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-1,000	Closed	–	–	766
2016 Q3	$0	Hold	1,000	–	–	﹤0.01%	771
2016 Q2	$0	Buy	+1,000	New	+$380	﹤0.01%	738

Other funds holding PVCT

CCB

Cutter & Co Brokerage Ballwin, Missouri $423M AUM 15.02% 1-Year Est. Return

HFBOT

Home Federal Bank of Tennessee Knoxville, Tennessee $463M AUM 24.62% 1-Year Est. Return

Jacobi Capital Management's PVCT Position: Q4 2016 in Review

Jacobi Capital Management sold out of PROVECTUS BIOPHARMACEUTICALS, INC. (DE) (PVCT) in Q4 2016, closing a stake of 1,000 shares.

Jacobi Capital Management first reported a position in PVCT in Q2 2016 and held it in 2 quarters. The position peaked at $0 in Q3 2016. 8 funds tracked by Wall St. Rank hold PVCT as of Q4 2016.

Jacobi Capital Management reported no remaining PROVECTUS BIOPHARMACEUTICALS, INC. (DE) position as of Q4 2016 after selling out during the quarter.
Jacobi Capital Management sold 1,000 PROVECTUS BIOPHARMACEUTICALS, INC. (DE) shares in Q4 2016.
Jacobi Capital Management first reported a position in PROVECTUS BIOPHARMACEUTICALS, INC. (DE) in Q2 2016 and held it in 2 quarters.
Jacobi Capital Management's PROVECTUS BIOPHARMACEUTICALS, INC. (DE) position peaked at $0 in Q3 2016.
8 funds tracked by Wall St. Rank held PROVECTUS BIOPHARMACEUTICALS, INC. (DE) as of Q4 2016.

Based on Jacobi Capital Management's 13F filing for Q4 2016, filed 8 Feb 2017.